0378-3266 : Vp-16 50 mg Oral Capsule


NDC: 0378-3266
Labeler: Mylan Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name: Etoposide
Dosage Form: Oral Capsule
Application #: ANDA075635
Rev. Date: 


Appearance:


Markings: E50
Shapes:  Capsule
Colors:  Pink
Size (mm): 23
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0378-3266-94: 20 CAPSULE IN 1 CARTON (0378‑3266‑94)

Active Ingredients:

  • Etoposide

Dosage Strength:

  • 50 mg

Inactive Ingredients:

  • Anhydrous Citric Acid
  • Glycerin
  • Polyethylene Glycols
  • Gelatin
  • Ferric Oxide Red
  • Titanium Dioxide
  • Fd&c Blue No. 1
  • Fd&c Red No. 40
  • Hypromelloses
  • Propylene Glycol

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0143-9376 Etoposide 20 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0143-9510 Etoposide 20 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9511 Etoposide 20 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9512 Etoposide 20 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 16729-114 Etoposide 20 mg/ml Intravenous Injection by Accord Healthcare Inc.
  • 16729-262 Etoposide 20 mg/ml Intravenous Injection by Accord Healthcare Inc.
  • 42605-031 Etoposide 20 mg/ml Intravenous Injection by Thymoorgan Gmbh Pharmazir & Co. K.g
  • 42605-032 Etoposide 20 mg/ml Intravenous Injection by Thymoorgan Gmbh Pharmazir & Co. K.g
  • 42605-033 Etoposide 20 mg/ml Intravenous Injection by Thymoorgan Gmbh Pharmazir & Co. K.g
  • 55390-291 Etoposide 20 mg/ml Intravenous Injection by Bedford Laboratories
  • 55390-292 Etoposide 20 mg/ml Intravenous Injection by Bedford Laboratories
  • 55390-293 Etoposide 20 mg/ml Intravenous Injection by Bedford Laboratories
  • 63323-104 Etoposide 20 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC
  • 68001-265 Etoposide 20 mg/ml Intravenous Injection by Bluepoint Laboratories

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0378-3266 QR Code

< Prev: 0378-3232Next: 0378-3286 >

Related Discussions:

Bleomycin + Etoposide
used with platinum for treating seminoma...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.